openPR Logo
Press release

Cerebrospinal Fluid Management Market to reach US$ 1,840.5 Mn in 2023

08-01-2016 08:34 AM CET | Health & Medicine

Press release from: TMR Research Report

Hydrocephalus is excessive accumulation of CSF inside the head caused due to disturbance of absorption, flow, or formation. The normal CSF production rate in adults is 0.35ml/ min. It indicates that 500 ml of CSF is produced in an entire day (24 hours). In normal situations, CSF is recycled three times in a day. Hydrocephalus is caused due to various reasons such as craniofacial anomalies, benign intracranial cysts, colloid cyst, choroid plexus tumor, intracranial hemorrhage, and meningitis. However, the overall care for patients with hydrocephalus has improved in the past 10 years due to better facilities, new approaches for treatment, and growing awareness.

Free Brochure Of Sample Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2590

Based on product type, the global CSF management market has been segmented into CSF shunts and CSF drainage systems. CSF drainage system is further classified into ventricular drainage system and lumbar drainage system. The market for these segments and sub-segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence.

Rise in incidence of neurological diseases and brain disorders, increasing geriatric population diagnosed with neurological diseases such as Alzheimer’s and Parkinson's diseases, growing demand for minimally invasive surgeries, and increased funding by government and private organizations are likely to fuel the growth of the market in the near future. The CSF management market is projected to expand at a CAGR of 5.5% during the forecast period from 2015 to 2023. Additionally, the development of healthcare infrastructure and rise in medical expenditure by governments and increase in disposable income by the people in emerging countries such as Brazil, India, China, and other countries in Asia and Latin America is likely to drive the CSF management market in the region. However, factors such as high cost of surgery and availability of CSF shunts can restrain the market. The report offers a detailed analysis of this high growth and outlines a possible growth trajectory at global as well as regional level in terms of value for each CSF management segment.

CSF shunts was the largest product segment of the market in 2014. CSF shunts allow brain to return to a normal size by relieving the symptoms of hydrocephalus. These also ease the process of getting samples of CSF by health care providers. However, the risk associated with CSF shunts such as it leads to infection that is caused due to the patient’s own skin organism such as Staphylococcus epidermis that gains access to shunt tubing during the shunt procedure. This contamination further leads to colonization of bacteria on internal wall of valve and shunt catheter leading to bacterial colonies. This shunt infection also leads to headache, vomiting, general malaise, pyrexia, etc. This acts as a limitation and can hinder the growth of the CSF management market. A CSF drainage system clears CSF from ventricles, eliminates blood clots from intrathecal spaces, and reduces the incidence of vasospasm. CSF drainage system is found to be more accurate and cost-effective. The segment is likely to expand at the highest CAGR during the forecast period. The report has been compiled in order to update the stakeholders with the incumbent market dynamics through a graphical illustration and in-depth analysis of major sub-segments for each region considered in the study scope.

Major players operating in the global market include DePuy Synthes (a J & J Company), Medtronic plc, B. Braun Melsungen AG, Sophysa S.A., Spiegelberg GmbH & Co. KG, Integra LifeSciences Holding Corporation, BeckerSmith Medical, Inc., and Möller Medical GmbH. The key market players are actively involved in constant innovations and developments related to technology and application to cater to the multi-dimensional needs of the end-users in order to maintain their positions in the global market.

Browse Full Report@ http://www.transparencymarketresearch.com/csf-management-market.html

About Us:-
Transparency Market Research is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us:-
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cerebrospinal Fluid Management Market to reach US$ 1,840.5 Mn in 2023 here

News-ID: 353112 • Views:

More Releases from TMR Research Report

Olive Oil Market - Global Industry Analysis, Forecast 2016 – 2024
Olive Oil Market - Global Industry Analysis, Forecast 2016 – 2024
Olive oil, an edible oil is being increasingly consumed by people from across the globe. Considering its nutritional value and the taste, olive oil is being consumed by a big pool of the global population. The market offers various types of olive oils such as extra virgin olive oil, light olive oil, pure olive oil, virgin olive oil, olive pomace oil, and refined olive oil. At present, the extra virgin
Iraq Edible Oils and Fats Market is Expected to Reach US$2.3 bn by 2025, Expandi …
The Iraq edible oils and fats market is extremely fragmented and the top seven players accounted for just under 90% of the overall market in 2015. These companies are Marsan Gida San Ve Tic A.S., Anadolu Group, Altunkaya Group of Companies, Zer Group, Aves A.S., Yildiz Holding, and Keskinoglu Ic Ve Dis Ticaret Ltd. Transparency Market Research has identified some of the successful strategies adopted by these enterprises in order
Government Support and Encouraging Regulations to be Key Growth Drivers for Glob …
In the highly fragmented competitive landscape of the global biomass boilers market, none of the leading companies accounted for a share of over 10% in the overall market in 2014, observes Transparency Market Research in a recent report. The top six companies in the market, including Baxi Group Limited, ETA Heiztechnik GmbH, Polytechnik Group, and Babcock & Wilcox Enterprises, Inc., collectively accounted for a relatively moderate 40% share in the
Wearable Technology Market to Show Unprecedented CAGR of 42.1% With Rising Trends of Cashless Payment
Wearable Technology Market to Show Unprecedented CAGR of 42.1% With Rising Trend …
While advances in material sciences in Europe have helped achieve unprecedented compactness in wearable devices, their adoption has received a boost because of their increasingly easy-to-use features. The prices of wearable technology products, however, continue to remain a hindrance to the growth of the European wearable technology market. The development of wearables for healthcare and fitness applications is a key opportunity that hitherto remains comparatively unexploited. By focusing on this

All 5 Releases


More Releases for CSF

G Csf And G Csf Biosimilars Market Size Trends and Forecast by Application, Type …
USA, New Jersey- According to Market Research Intellect, the global G Csf And G Csf Biosimilars market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The G-CSF and G-CSF biosimilars market is witnessing steady growth, largely due to increasing demand for affordable treatments for neutropenia, especially
G-CSF & G-CSF Biosimilars Market Growth 2032: Increasing Cancer Treatment Demand …
The global market for Granulocyte Colony Stimulating Factor (G-CSF) and G-CSF biosimilars is on a promising growth trajectory as the demand for cost-effective and therapeutic alternatives to branded drugs increases. G-CSF and its biosimilars are vital in treating neutropenia, leukopenia, platelet disorders, and various types of cancer, and their growing adoption is fueled by technological advancements and supportive government policies. The market size was valued at $5.89 billion USD in 2023
G-CSF and G-CSF Biosimilars Market Size, Growth and Forecast 2021 to 2028 By Ame …
The worldwide G-CSF and G-CSF Biosimilars market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner
G-CSF and G-CSF Biosimilars Market Size to Witness Huge Growth by 2027: Pfizer, …
G-CSF and G-CSF Biosimilars market Research Report LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application“. This report offers an insightful take on the drivers and restraints present in the market. G-CSF and G-CSF Biosimilars data reports also provide a 5 year pre-historic and forecast
Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novar …
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation. Request Sample Copy of Report @ https://www.researchtrades.com/request-sample/1664081 This report studies
China CSF Management Market Outlook to 2023
New report, "China CSF Management Market Outlook to 2023", provides key market data on theChina CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Hydrocephalus Shunts and Dura Substitutes. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on